研發創新開創液劑新標竿

晟德大藥廠以液劑藥品的專業製造定位，致力於研發多元化的液劑系列產品。透過先進的技術平台整合、專業處方研究，以及處方設計分析等能力，企業逐年都以創新開發3~5種新品項的實績；因而得以持續強化創新競爭力。

以包裹苦味技術為例，我們成功克服了內服液劑藥品的苦味問題，同時亦解決多種藥品在水中安定性及溶解度等困難。又如針對嬰幼孩童的新藥品發展上，分析其服藥不易的原因以及藥性調節問題，持續開發出有關呼吸道、腸胃道、中樞神經、心血管等內服液劑用藥；並特別進行兒童好發性疾病（如氣喘、過敏等）與罕見疾病的藥品開發。

近年來，晟德積極投入CNS液劑藥品的開發，結合臨床研究組織（CRO）與各大醫學中心進行實驗，為液劑藥品的新劑型及新複方提供有效的解決新途徑。

致力於亞洲最專業的生技液劑藥廠

晟德大藥廠目前已為液劑藥品的領導廠商之一，企業從尊重、愛及關懷出發，整合價值體系而使每個環結均能具最適化運作，創造企業員工、股東及社會投資大眾的最大效益。未來，我們將致力成為亞洲最專業的生技液劑藥廠，目標面向有五：

‧技術研發面

結合民間學術單位，引進關鍵性突破技術，以強化小分子、奈米化的創新技術。

‧產品開發面

發展多元化新型液劑藥品，並將投入CNS藥品研究，以切合市場需求。

‧市場發展面

國內市場將強化既有經銷通路體系的整合；國外市場將以中國大陸為發展中心，並積極尋求韓國、日本、東南亞等區域的合作夥伴，共同擴展當地市場。

‧品牌資產面

以液劑藥品開創品牌知名度、識別度、優質形象及附加價值服務，建立市場領先地位及強大的品牌資產。

‧生產製造面

以國際認證標準為基礎，突破製造技術水準；並積極爭取與國際大廠合作生產液劑藥品的機會。

 R&D Setting New Liquid Drug Benchmarks

Center Laboratories specializes in the manufacture of liquid drugs, and are devoted to developing a wide range of liquid drug products. We have taken advantage of our advanced integrated technology platform, professional formulation research, and formulation design analysis capabilities to successfully develop 3~5 new products each year for several years. Our innovation and competitiveness are hard to match.

In addition to packaging bitter-tasting drugs in a way that overcomes the bitter taste of oral liquid drugs, we have also resolved many drugs' solubility and aqueous stability problems. Our development of new drugs for infants and children is informed by analyses of why the drug may be hard to take or problems involving adjustment of a drug's properties. We are continuing to develop oral liquid drugs for respiratory, gastrointestinal, central nervous system and cardiovascular disorders. We are putting particular effort into the development of drugs for children's health conditions (including asthma and allergies) and rare diseases.

We have paid particular attention to the development of long-lasting liquid drugs in recent years. We are testing our new drugs together with Clinical Research Organizations (CROs) and major medical centers as we explore new liquid drug dosage forms and new formulations.

Becoming Asia's Most Professional Biotech Liquid Drug Manufacturer

Center Laboratories are already one of the world's leading manufacturers of liquid drugs. We strive to ensure that every effort yields the greatest benefits for our employees, stockholders, and the investing public. We are devoted to becoming Asia's premier biotech liquid drug manufacturer.

‧Technology R&D

We plan to acquire key technologies through alliances with private academic organizations.

‧Product Development

We will develop a wide range of new liquid drugs and meet the market need for drugs for adult chronic diseases.

‧Market Development

We will strengthen integration of our existing distribution system in the domestic market. China will serve as our foreign market development center and we will actively search for partners in Korea, Japan, and Southeast Asia.

‧Brand Assets

We will establish ourselves as the market leader through our strong brand assets, which include brand recognition, a superior image and added-value service.

‧Production

We will continue to improve our manufacturing technology while adhering closely to international certification standards and cooperate with international brands.